Home/GenVivo/Robert Johnson, M.D., Ph.D.
RJ

Robert Johnson, M.D., Ph.D.

Chief Operating Officer

GenVivo

Therapeutic Areas

GenVivo Pipeline

DrugIndicationPhase
In Vivo CAR-T ProgramsCancer (Oncology)Pre-clinical